ArticleJournal of medicine and life2025
Knowledge and practice of deep brain stimulation among pediatric neurology residents in Saudi Arabia.
Article in Journal of medicine and life, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep brain stimulation (DBS) is an established neurosurgical intervention for movement disorders, yet awareness among Saudi pediatric neurology residents remains limited. This study assessed the knowledge, attitudes, and perceived barriers to DBS among Saudi pediatric neurology trainees. A cross-sectional survey was conducted among pediatric neurology residents in Saudi Arabia. Participants completed a structured questionnaire assessing their familiarity with DBS indications, procedural knowledge, and training exposure. Descriptive and inferential statistics were applied. A total of 40 pediatric neurology residents participated, with a majority (87.5%) aged 26-30 years and 57.5% being women. While 65% recognized DBS as FDA-approved for adults, only 50% were aware of its pediatric approval. Knowledge of DBS targets was moderate (65%), but awareness of side effects (45%) and genetic factors influencing DBS outcomes (32.5%) was limited. Exposure to DBS-related activities was minimal, with 95% never attending a family discussion, 100% never witnessing a DBS surgery, and 80% never attending a DBS lecture. Higher residency years correlated with better DBS knowledge (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.